Retirement Planning CO Of New England, Inc. Oncolytics Biotech Inc Transaction History

Retirement Planning CO Of New England, Inc.

$182 Million
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 06, 2022	SELL	$1.31 - $2.02 $55 - $84	-42 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$1.39 - $2.3 $58 - $96	42 New	42 $0

Others Institutions Holding ONCY

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

Morgan Stanley New York, NY

348K
Shares

$358,762
0.0% of portfolio
International Assets Investment Management, LLC Orlando, FL

201K
Shares

$207,495
0.02% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

163K
Shares

$167,647
0.0% of portfolio
Goldman Sachs Group Inc New York, NY

83.6K
Shares

$86,105
0.0% of portfolio
Commonwealth Equity Services, LLC

62.8K
Shares

$64,646
0.0% of portfolio

View Full List

About ONCOLYTICS BIOTECH INC

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $59.6M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

More about ONCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Planning CO Of New England, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Retirement Planning CO Of New England, Inc. with notifications on news.

Account